Your browser doesn't support javascript.
loading
The Risk of Tuberculosis in Patients With Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab in Korea.
Choi, Myeong Geun; Ye, Byong Duk; Yang, Suk-Kyun; Shim, Tae Sun; Jo, Kyung-Wook; Park, Sang Hyoung.
Affiliation
  • Choi MG; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Ye BD; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mokdong Hospital, College of Medicine, Ewha Womans University, Seoul, Korea.
  • Yang SK; Department of Gastroenterology and Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Shim TS; Department of Gastroenterology and Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Jo KW; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Park SH; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. heathcliff6800@hanmail.net.
J Korean Med Sci ; 37(14): e107, 2022 Apr 11.
Article in En | MEDLINE | ID: mdl-35411727

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Inflammatory Bowel Diseases Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Korean Med Sci Journal subject: MEDICINA Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Inflammatory Bowel Diseases Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Korean Med Sci Journal subject: MEDICINA Year: 2022 Type: Article